Skip to main navigation
Skip to search
Skip to main content
Maastricht University Home
Support & FAQ
Link opens in a new tab
Search content at Maastricht University
Home
Researchers
Publications
Activities
Press/Media
Prizes
Organisations
Dataset/Software
Projects
MicroRNA-126,-145, and -155 A Therapeutic Triad in Atherosclerosis?
Yuanyuan Wei
, Maliheh Nazari-Jahantigh
, Peter Neth
,
Christian Weber
, Andreas Schober
*
*
Corresponding author for this work
CARIM - Cardiovascular Research Institute Maastricht
Research output
:
Contribution to journal
›
Article
›
Academic
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'MicroRNA-126,-145, and -155 A Therapeutic Triad in Atherosclerosis?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Endothelial Cells
100%
MiR-126
100%
MicroRNA
66%
MicroRNA-155 (miR-155)
66%
Smooth muscle Cells
66%
MiR-145
66%
Cardiovascular Disease
33%
Treatment Options
33%
Gene Expression
33%
Inflammation
33%
Lipids
33%
Complex Interplay
33%
Macrophages
33%
Atherosclerotic Lesions
33%
Vessel Wall
33%
Disease Conditions
33%
Atherogenesis
33%
Advanced Atherosclerosis
33%
Inflammatory Macrophages
33%
Cell Fate
33%
Cell Function
33%
Endothelial Repair
33%
Early Atherosclerosis
33%
Microvesicles
33%
Target mRNA
33%
Novel Treatments
33%
Lesion Formation
33%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Macrophage
100%
Mir-126
100%
MiR-155
100%
Mir-145
100%
Downregulation
50%
Lipid
50%
Gene Expression
50%
Cell Function
50%
Microvesicles
50%
Cell Fate
50%
Messenger RNA
50%
Medicine and Dentistry
Atherosclerosis
100%
microRNA 126
100%
Endothelial Cell
60%
Macrophage
40%
Smooth Muscle Cell
40%
microRNA
40%
microRNA 155
40%
Mir-145
40%
Cardiovascular Disease
20%
Gene Expression
20%
Downregulation
20%
Atherogenesis
20%
Cellular Physiology
20%
Messenger RNA
20%
Diseases
20%
Cell Fate
20%
INIS
atherosclerosis
100%
muscles
40%
macrophages
40%
diseases
20%
levels
20%
walls
20%
cardiovascular diseases
20%
control
20%
vessels
20%
genes
20%
repair
20%
inflammation
20%
messenger-rna
20%
in vivo
20%
signals
20%
lipids
20%
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
100%
microRNA 126
100%
microRNA
40%
microRNA 155
40%
microRNA 145
40%
Inflammation
20%
Atherogenesis
20%
Cardiovascular Disease
20%
Messenger RNA
20%
Diseases
20%
Immunology and Microbiology
Atherosclerosis
100%
Macrophage
40%
Smooth Muscle Cell
40%
Downregulation
20%
Gene Expression
20%
Cell Function
20%
Cell Fate
20%